| Date post: | 15-Apr-2017 |
| Category: |
Health & Medicine |
| Upload: | imarc-group |
| View: | 583 times |
| Download: | 2 times |
Indian Vaccine Market Report
and Forecast 2015-2019
Imarcwww.imarcgroup.com
Copyright © 2015 International Market Analysis Research & Consulting (IMARC). All Rights Reserved
Consulting Services
The International Market Analysis Research and Consulting Group is a leading advisor onmanagement strategy and market research worldwide. We partner with clients in all sectors andregions to identify their highest-value opportunities, address their most critical challenges, andtransform their businesses.
IMARC’s information products include major market, scientific, economic and technologicaldevelopments for business leaders in pharmaceutical, industrial, and high technology organizations.Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals,food and beverage, travel and tourism, nanotechnology and novel processing methods are at thetop of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies andmarkets with close cooperation at all levels of the client organization. This ensures that our clientsachieve unmatchable competitive advantage, build more proficient organizations, and secure lastingresults.
About IMARC GroupImarc
www.imarcgroup.com
Report Description and HighlightsImarc
www.imarcgroup.com
The Indian Vaccine Market: Current Market Trends and Future Prospects
A new report expects the Indian vaccine market to grow at a CAGR of 15% in the coming years. The sustainedgrowth of the Indian economy, a consequent rise in public and private healthcare expenditures, 25-30 millionbirths every year and a strong growth in the market for adult vaccines are expected to be the main factorscatalyzing this growth.
The market for vaccines in India shows immense potential. The country has not only been self-sufficient inmeeting its domestic requirements but has also emerged as a leading global exporter of vaccines across theworld. The Indian vaccine industry began as a network of state owned manufacturers supplying basic childhoodvaccines to the national immunization programme. In recent decades, however, a number of privately ownedfirms have emerged which have completely transformed the industry landscape. Their biggest success factor issimilar to the approach that has been followed by Indian generic pharmaceutical manufacturers. This modelinvolved concerted efforts to develop vaccines for not only tropical neglected diseases, but also cheaperalternatives of vaccines that are already available in the West.
Despite its recent growth, however, the Indian vaccine industry still has a number of challenges to address. Themarket remains small (currently accounts for less than 2% of the global market) and underpenetrated comparedto the developed countries. The country also lags behind its global peers in terms of vaccine coverage with asignificant number of lives lost due to vaccine preventable deaths. Nevertheless, despite these challenges thesituation appears bright for vaccine manufacturers. The country has around 25-30 Million births each year. Thiscoupled with the sustained growth of the Indian economy, a consequent rise in public and private healthcareexpenditures and a strong growth in the market for adult vaccines is expected to propel the Indian vaccinemarket to grow at a CAGR of over 15% during the coming years.
Report Description and HighlightsImarc
www.imarcgroup.com
IMARC’s new report entitled “Indian Vaccine Market Report and Forecast 2015-2019” provides an analytical andstatistical insight into the Indian vaccine market. The study is an outcome of an intensive research on the Indianvaccine industry and draws upon a comprehensive analysis of every major vaccine in India. The report can serveas an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planningto foray into the Indian vaccine market in any form.
Key Vaccines Covered in the Report
BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella,DPT, Polio, MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV
Focus of the Analysis for Each Vaccine
• Vaccine Overview and Epidemiology• Historical and Current Market Trends• Market Breakup by Prescriber• Market Breakup by Public and Private Sector• Market Outlook
Table of Contents
1. Research Methodology and Market Definitions2. Executive Summary3. Indian Vaccine Market3.1 Introduction and History3.2 Current and Historical Market Trends
Indian Vaccine MarketImarc
www.imarcgroup.com
Report Description and HighlightsImarc
www.imarcgroup.com
3.3 Market Breakup by Segment3.4 Market Breakup by Key Players3.5 Market Drivers and Challenges3.6 Market Outlook4. Market Analysis of Various Monovalent and Combined Vaccines4.1 BCG Vaccine Market4.1.1 Vaccine Overview and Epidemiology4.1.2 Historical and Current Market Trends4.1.3 Market Breakup by Prescriber4.1.4 Market Breakup by Public and Private Sectors 4.1.5 Market Outlook4.2 HIB Vaccine Market4.2.1 Vaccine Overview and Epidemiology4.2.2 Historical and Current Market Trends4.2.3 Market Breakup by Prescriber4.2.4 Market Breakup by Public and Private Sectors 4.2.5 Market Outlook4.3 Influenza Vaccine Market4.3.1 Vaccine Overview and Epidemiology4.3.2 Historical and Current Market Trends4.3.3 Market Breakup by Prescriber4.3.4 Market Breakup by Public and Private Sectors 4.3.5 Market Outlook4.4 Varicella Vaccine Market4.4.1 Vaccine Overview and Epidemiology
Report Description and HighlightsImarc
www.imarcgroup.com
4.4.2 Historical and Current Market Trends4.4.3 Market Breakup by Prescriber4.4.4 Market Breakup by Public and Private Sectors 4.4.5 Market Outlook4.5 Typhoid Vaccine Market4.5.1 Vaccine Overview and Epidemiology4.5.2 Historical and Current Market Trends4.5.3 Market Breakup by Prescriber4.5.4 Market Breakup by Public and Private Sectors 4.5.5 Market Outlook4.6 Japanese Encephalitis Vaccine Market4.6.1 Vaccine Overview and Epidemiology4.6.2 Historical and Current Market Trends4.6.3 Market Breakup by Prescriber4.6.4 Market Breakup by Public and Private Sectors 4.6.5 Market Outlook4.7 Measles Vaccine Market4.7.1 Vaccine Overview and Epidemiology4.7.2 Historical and Current Market Trends4.7.3 Market Breakup by Prescriber4.7.4 Market Breakup by Public and Private Sectors 4.7.5 Market Outlook4.8 Tetanus Toxoid Vaccine Market4.8.1 Vaccine Overview and Epidemiology4.8.2 Historical and Current Market Trends
Report Description and HighlightsImarc
www.imarcgroup.com
4.8.3 Market Breakup by Prescriber4.8.4 Market Breakup by Public and Private Sectors 4.8.5 Market Outlook4.9 Hepatitis A Vaccine Market4.9.1 Vaccine Overview and Epidemiology4.9.2 Historical and Current Market Trends4.9.3 Market Breakup by Prescriber4.9.4 Market Breakup by Public and Private Sectors 4.9.5 Market Outlook4.10 Rubella Vaccine Market4.10.1 Vaccine Overview and Epidemiology4.10.2 Historical and Current Market Trends4.10.3 Market Breakup by Prescriber4.10.4 Market Breakup by Public and Private Sectors 4.10.5 Market Outlook4.11 DPT Vaccine Market4.11.1 Vaccine Overview and Epidemiology4.11.2 Historical and Current Market Trends4.11.3 Market Breakup by Prescriber4.11.4 Market Breakup by Public and Private Sectors 4.11.5 Market Outlook4.12 Polio Vaccine Market4.12.1 Vaccine Overview and Epidemiology4.12.2 Historical and Current Market Trends4.12.3 Market Breakup by Prescriber
Report Description and HighlightsImarc
www.imarcgroup.com
4.12.4 Market Breakup by Public and Private Sectors 4.12.5 Market Outlook4.13 MMR Vaccine Market4.13.1 Vaccine Overview and Epidemiology4.13.2 Historical and Current Market Trends4.13.3 Market Breakup by Prescriber4.13.4 Market Breakup by Public and Private Sectors 4.13.5 Market Outlook4.14 Rotavirus Vaccine Market4.14.1 Vaccine Overview and Epidemiology4.14.2 Historical and Current Market Trends4.14.3 Market Breakup by Prescriber4.14.4 Market Breakup by Public and Private Sectors4.14.5 Market Outlook4.15 Hepatitis B Vaccine Market4.15.1 Vaccine Overview and Epidemiology4.15.2 Historical and Current Market Trends4.15.3 Market Breakup by Prescriber4.15.4 Market Breakup by Public and Private Sectors 4.15.5 Market Outlook4.16 Pneumococcal Vaccine Market4.16.1 Vaccine Overview and Epidemiology4.16.2 Historical and Current Market Trends4.16.3 Market Breakup by Prescriber4.16.4 Market Breakup by Public and Private Sectors
Report Description and HighlightsImarc
www.imarcgroup.com
4.16.5 Market Outlook4.17 Meningococcal Vaccine Market4.17.1 Vaccine Overview and Epidemiology4.17.2 Historical and Current Market Trends4.17.3 Market Breakup by Prescriber4.17.4 Market Breakup by Public and Private Sectors 4.17.5 Market Outlook4.18 Rabies Vaccine Market4.18.1 Vaccine Overview and Epidemiology4.18.2 Historical and Current Market Trends4.18.3 Market Breakup by Prescriber4.18.4 Market Breakup by Public and Private Sectors 4.18.5 Market Outlook4.19 HPV Vaccine Market4.19.1 Vaccine Overview and Epidemiology4.19.2 Historical and Current Market Trends4.19.3 Market Breakup by Prescriber4.19.4 Market Breakup by Public and Private Sectors 4.19.5 Market Outlook5. Regulatory Framework
Report Description and HighlightsImarc
www.imarcgroup.com
List of Figures
Figure 1: Vaccine Development and Introduction in Indian Vaccine MarketFigure 2: Comparison of Global Vaccine Market and Indian Vaccine MarketFigure 3: India: Vaccine Market: Sales Value (in Billion INR), 2007 - 2014Figure 4: India: Vaccine Market: Healthcare and Immunization Budget (In Billion INR), 2007 - 2014Figure 5: India: Vaccine Market: Standard Procedure of Introducing New VaccineFigure 6: India: Vaccine Market: Spending by Different Organizations on Polio Program Figure 7: India: Vaccine Market: Vaccine Coverage in Uttar Pradesh and Tamil Nadu Figure 8: India: Vaccine Market: Value Breakup by Therapies (in %), 2014Figure 9: India: Monovalent Vaccine Market: Value Breakup by Vaccine (in %), 2014Figure 10: India: Combined Vaccine Market: Value Breakup by Vaccine (in %), 2014Figure 11: India: Vaccine Market: Value Breakup by Key Players (in %), 2014Figure 12: India: BCG Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 13: India: BCG Vaccine Market: Doses Administered (in Million), 2007 - 2014Figure 14: India: BCG Vaccine Market: Breakup by Prescriber (in %), 2014Figure 15: India: BCG Vaccine Market: Breakup by Sector (in %), 2014Figure 16: India: BCG Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 17: India: BCG Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 18: India: HIB Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 19: India: HIB Vaccine Market: Doses Administered (in ‘000), 2007 - 2014Figure 20: India: HIB Vaccine Market: Breakup by Prescriber (in %), 2014Figure 21: India: HIB Vaccine Market: Breakup by Sector (in %), 2014Figure 22: India: HIB Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 23: India: HIB Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 24: India: Influenza Vaccine Market: Sales value (in Million INR), 2010 - 2014
Report Description and HighlightsImarc
www.imarcgroup.com
Figure 25: India: Influenza Vaccine Market: Doses Administered (in Million), 2010 - 2014Figure 26: India: Influenza Vaccine Market: Breakup by Prescriber (in %), 2014Figure 27: India: Influenza Vaccine Market: Breakup by Sector (in %), 2014Figure 28: India: Influenza Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 29: India: Influenza Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019 Figure 30: India: Varicella Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 31: India: Varicella Vaccine Market: Doses Administered (in Million), 2007 - 2014Figure 32: India: Varicella Vaccine Market: Breakup by Prescriber (in %), 2014Figure 33: India: Varicella Vaccine Market: Breakup by Sector (in %), 2014Figure 34: India: Varicella Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 35: India: Varicella Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 36: India: Typhoid Vaccine Market: Sales value (in Million INR), 2007 - 2014 Figure 37: India: Typhoid Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 38: India: Typhoid Vaccine Market: Breakup by Prescriber (in %), 2014Figure 39: India: Typhoid Vaccine Market: Breakup by Sector (in %), 2014Figure 40: India: Typhoid Vaccine Market: Sales Value Forecast (in Millions INR), 2015 - 2019Figure 41: India: Typhoid Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 42: India: JE Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 43: India: JE Vaccine Market: Doses Administered (in Million), 2007 - 2014Figure 44: India: JE Vaccine Market: Breakup by Prescriber (in %), 2014Figure 45: India: JE Vaccine Market: Breakup by Sector (in %), 2014Figure 46: India: JE Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 47: India: JE Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 48: India: Measles Vaccine Market: Sales Value (in Million INR), 2007 – 2014Figure 49: India: Measles Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 50: India: Measles Vaccine Market: Breakup by Prescriber (in %), 2014
Report Description and HighlightsImarc
www.imarcgroup.com
Figure 51: India: Measles Vaccine Market: Breakup by Sector (in %), 2014Figure 52: India: Measles Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 53: India: Measles Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 54: India: TT Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 55: India: TT Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 56: India: TT Vaccine Market: Breakup by Prescriber (in %), 2014Figure 57: India: TT Vaccine Market: Breakup by Sector (in %), 2014Figure 58: India: TT Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 59: India: TT Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 60: India: Hepatitis A Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 61: India: Hepatitis A Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 62: India: Hepatitis A Vaccine Market: Breakup by Prescriber (in %), 2014Figure 63: India: Hepatitis A Vaccine Market: Breakup by Sector (in %), 2014Figure 64: India: Hepatitis A Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 65: India: Hepatitis A Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 66: India: Rubella Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 67: India: Rubella Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 68: India: Rubella Vaccine Market: Breakup by Prescriber (in %), 2014Figure 69: India: Rubella Vaccine Market: Breakup by Sector (in %), 2014Figure 70: India: Rubella Vaccine Market: Sales Value Forecast (in Million INR), 2015 – 2019Figure 71: India: Rubella Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 72: India: DPT Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 73: India: DPT Vaccine Market: Doses Administered (in Million), 2007 - 2014 Figure 74: India: DPT Vaccine Market: Breakup by Prescriber (in %), 2014Figure 75: India: DPT Vaccine Market: Breakup by Sector (in %), 2014Figure 76: India: DPT Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019
Report Description and HighlightsImarc
www.imarcgroup.com
Figure 77: India: DPT Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 78: India: Polio Vaccine: Incidence of Polio, 2007 - 2014Figure 79: India: Polio Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 80: India: Polio Vaccine Market: Doses Administered (in Million), 2007 - 2014Figure 81: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014Figure 82: India: Polio Vaccine Market: Breakup by Sector (in %), 2014Figure 83: India: Polio Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 84: India: Polio Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 85: India: MMR Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 86: India: MMR Vaccine Market: Doses Administered (in Million), 2007 - 2014Figure 87: India: MMR Vaccine Market: Breakup by Prescriber (in %), 2014Figure 88: India: MMR Vaccine Market: Breakup by Sector (in %), 2014Figure 89: India: MMR Vaccine Market: Sales Value Forecast (in INR Million), 2015 - 2019Figure 90: India: MMR Vaccine Market: Doses Administered Forecast (In Million), 2015 - 2019Figure 91: India: Rotavirus Vaccine Market: Sales Value (in Million INR), 2010-2014Figure 92: India: Rotavirus Vaccine Market: Doses Administered (in Million), 2010-2014Figure 93: India: Rotavirus Vaccine Market: Breakup by Prescriber (In %), 2014Figure 94: India: Rotavirus Vaccine Market: Breakup by Sector (in %), 2014Figure 95: India: Rotavirus Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 96: India: Rotavirus Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 97: India: Hepatitis B Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 98: India: Hepatitis B Vaccine Market: Doses Administered (in Million), 2007 - 2014Figure 99: India: Hepatitis B Vaccine Market: Breakup by Prescriber (in %), 2014Figure 100: India: Hepatitis B Vaccine Market: Breakup by Sector (in %), 2014Figure 101: India: Hepatitis B Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 102: India: Hepatitis B Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Report Description and HighlightsImarc
www.imarcgroup.com
Figure 103: India: Pneumonia Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 104: India: Pneumonia Vaccine Market: Doses Administered (in Million), 2007 - 2014Figure 105: India: Pneumonia Vaccine Market: Breakup by Prescriber (in %), 2014Figure 106: India: Pneumonia Vaccine Market: Breakup by Sector (in %), 2014Figure 107: India: Pneumonia Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 108: India: Pneumonia Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 109: India: Meningococcal Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 110: India: Meningococcal Vaccine Market: Doses Administered (in Million), 2007 - 2014Figure 111: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014Figure 112: India: Polio Vaccine Market: Breakup by Sector (in %), 2014Figure 113: India: Meningococcal Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 114: India: Meningococcal Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 115: India: Rabies Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 116: India: Rabies Vaccine Market: Doses Administered (in Million), 2007 - 2014Figure 117: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2014Figure 118: India: Polio Vaccine Market: Breakup by Sector (in %), 2014Figure 119: India: Rabies Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 120: India: Rabies Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019Figure 121: India: HPV Vaccine Market: Sales Value (in Million INR), 2007 - 2014Figure 122: India: HPV Vaccine Market: Doses Administered (in Million), 2007 - 2014Figure 123: India: HPV Vaccine Market: Breakup by Prescriber (in %), 2014Figure 124: India: HPV Vaccine Market: Breakup by Sector (in %), 2014Figure 125: India: HPV Vaccine Market: Sales Value Forecast (in Million INR), 2015 - 2019Figure 126: India: HPV Vaccine Market: Doses Administered Forecast (in Million), 2015 - 2019
Report Description and HighlightsImarc
www.imarcgroup.com
List of Tables
Table 1: India: Vaccine Market OverviewTable 2: India: Monovalent Vaccine Market: Value Breakup by Vaccine, 2014 and 2019Table 3: India: Combined Vaccine Market: Value Breakup by Vaccine, 2014 and 2019Table 4: India: Vaccine Market: Structural BarriersTable 5: India: BCG Vaccine: OverviewTable 6: India: BCG Vaccine: Incidence of TB, 2013Table 7: India: HIB Vaccine: OverviewTable 8: India: HIB Vaccine: Incidence of HIB, 2006 and 2013Table 9: India: Influenza Vaccine: OverviewTable 10: India: Influenza Vaccine: Incidence of Influenza, 2011 and 2013Table 11: India: Varicella Vaccine: OverviewTable 12: India: Varicella Vaccine: Incidence of Chickenpox, 2013Table 13: India: Typhoid Vaccine: OverviewTable 14: India: Typhoid Vaccine: Incidence of Typhoid, 2013Table 15: India: JE Vaccine: OverviewTable 16: India: JE Vaccine: Incidence of JE, 2012 and 2013Table 17: India: Measles Vaccine: OverviewTable 18: India: Measles Vaccine: Incidence, 2007 - 2013Table 19: India: Tetanus Toxoid Vaccine: OverviewTable 20: India: Tetanus Toxoid Vaccine: Incidence of Tetanus Toxoid, 2007 – 2013Table 21: India: Hepatitis A Vaccine: OverviewTable 22: India: Hepatitis A Vaccine: Incidence of Hepatitis A, 2012 and 2013
Report Description and HighlightsImarc
www.imarcgroup.com
Table 23: India: Rubella Vaccine: OverviewTable 24: India: Rubella Vaccine: Incidence of RubellaTable 25: India: DPT Vaccine: OverviewTable 26: India: DPT Vaccine: Incidence of DPT, 2007 - 2013Table 27: India: Polio Vaccine: OverviewTable 28: India: MMR Vaccine: OverviewTable 29: India: MMR Vaccine: Incidence of Measles, Mumps & Rubella, 2011 and 2013Table 30: India: Rotavirus Vaccine: OverviewTable 31: India: Rotavirus Vaccine: Incidence of Rotavirus, 2013Table 32: India: Hepatitis B Vaccine: OverviewTable 33: India: Hepatitis B Vaccine: Incidence of Hepatitis B, 2011 and 2014Table 34: India: Pneumonia Vaccine: OverviewTable 35: India: Pneumonia Vaccine: Incidence of Pneumonia, 2012 and 2013Table 36: India: Meningococcal Vaccine: OverviewTable 37: India: Meningococcal Vaccine: Incidence of Meningococcal, 2007 and 2013Table 38: India: Rabies Vaccine: OverviewTable 39: India: Rabies Vaccine: Incidence of Rabies, 2013Table 40: India: HPV Vaccine: OverviewTable 41: India: HPV Vaccine: Incidence of HPV, 2007 and 2014
Report Description and HighlightsImarc
www.imarcgroup.com
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia:Email: [email protected]: +91-120-415-5099
IMARC Group North America:Email: [email protected]: +1-631-791-1145
IMARC Group Europe, Middle East & Africa:Email: [email protected]: +44-702-409-7331
To know more please visit: http://www.imarcgroup.com/indian-vaccine-market
Report Description and HighlightsImarc
www.imarcgroup.com
© 2015 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name ofInternational Market Analysis Research and Consulting (IMARC). No part of this publication may bereproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not beused in any form or by and means graphic electronic or mechanical, including photocopying, recording,taping or by information storage or retrieval, or by any other form, without the express consent ofInternational Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have beenbased on information and sources believed to be accurate and reliable at the time of publishing.International Market Analysis Research and Consulting makes no representation of warranty of any kind as tothe accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for anyloss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International MarketAnalysis Research and Consulting. All other trademarks used in this publication are registered trademarks oftheir respective companies.
FOR MORE DETAILS
Visit us at :
http://www.imarcgroup.com
Stay With Us:
TELEPHONE: +91-120-4155099
E-MAIL: [email protected]
Imarcwww.imarcgroup.com
